Quanterra Sleep 400 mg Tablet is a Health Canada–registered human drug (DIN 02239865) held by Warner-Lambert Canada Inc., containing Melissa Officinalis. Health Canada lists its status as Cancelled Pre Market (status date 02 Aug 2017). Nexara Health has matched 5 registrations of Melissa Officinalis across 2 other regulated markets.
Health Canada registration
| DIN | 02239865 |
|---|---|
| Brand name | Quanterra Sleep |
| Active ingredient | Melissa Officinalis |
| Strength | 400 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Warner-Lambert Canada Inc. |
| Status | Cancelled Pre Market — 02 Aug 2017 |
| Class | Human |
| ATC | |
| AHFS | 84:04.92 |
| Regulator record | Health Canada DPD entry · Product monograph |
Melissa Officinalis registered in other markets
5 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Melissa officinalis | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Druppels voor oraal gebruik, oplossing | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Melissa officinalis | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Melissa officinalis | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Melissa officinalis | Heel Belgium n.v. | D4 t/m D200#2CH t/m 200CH#6K t/m 50.000K#LM1 t/m LM30 | Uitsluitend apotheek of drogist | EU national register | |
| United States | Melissa officinalis | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Melissa Officinalis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Quanterra Sleep (DIN 02239865) marketed in Canada?
No. Health Canada lists DIN 02239865 as Cancelled Pre Market as of 02 Aug 2017.
Who holds the Canadian licence for this product?
Warner-Lambert Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Melissa Officinalis registered outside Canada?
Yes — Nexara Health has matched 5 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02239865, status date 2017-08-02; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02239865, status date 2017-08-02; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02239865, status date 2017-08-02; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.